Neumora Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$43 | −$53 | −$57 | −$53 | −$68 | −$73 | −$59 | −$54 | |
| −$0.23 | −$0.30 | −$0.35 | −$0.33 | −$0.42 | −$0.45 | −$0.37 | −$0.34 | |
| 185 | 180 | 162 | 162 | 161 | 160 | 159 | 158 |
Trend